Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

ClinicalTrials.gov ID: NCT02932943

Public ClinicalTrials.gov record NCT02932943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and tolerability of rapastinel 450 mg compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Study identification

NCT ID
NCT02932943
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
465 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2016 (Actual)
Primary completion
Sep 21, 2018 (Actual)
Completion
Nov 8, 2018 (Actual)
Last update posted
Oct 11, 2019

2016 – 2018

United States locations

U.S. sites
31
U.S. states
12
U.S. cities
31
Facility City State ZIP Site status
Southern California Research LLC. Beverly Hills California 90036 —
ATP Clinical Research Inc. Costa Mesa California 92626 —
Pharmacology Research Institute Encino California 91316 —
Collaborative Neuroscience Network, LLC Garden Grove California 92845 —
Synergy San Diego Lemon Grove California 91945 —
Pharmacology Research Institute Los Alamitos California 90720 —
Excell Research Oceanside California 92056 —
Anderson Clinical Research Redlands California 92374 —
Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc., Sherman Oaks California 91403 —
Viking Clinical Research Temecula California 92591 —
Pacific Clinical Research Medical Upland California 91786 —
Comprehensive Psychiatric Care Norwich Connecticut 06360 —
Meridien Research Bradenton Florida 34201 —
MD Clinical Hallandale Florida 33009 —
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32256 —
Meridien Research Lakeland Florida 33805 —
Institute for Advanced Medical Research Alpharetta Georgia 30005 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
Adams Clinical Trials Watertown Massachusetts 02472 —
Altea Research Las Vegas Nevada 89102 —
Bioscience Research Mount Kisco New York 10549 —
Eastside Comprehensive Medical Center, LLC New York New York 10128 —
Finger Lakes Clinical Research Rochester New York 14618 —
Neuro-Behavioral Clinical Research, Inc Canton Ohio 44718 —
University of Cincinnati Cincinnati Ohio 45219 —
Midwest Clinical Research Center LLC Dayton Ohio 45417 —
IPS Research Oklahoma City Oklahoma 73103 —
Clinical Neuroscience Solutions, Inc Memphis Tennessee 38119 —
Donald J. Garcia, Jr., MD, PA Austin Texas 78737 —
Clinical Trials of Texas San Antonio Texas 78229 —
NorthWest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02932943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02932943 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →